These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2101948)

  • 21. The treatment of chest infections.
    Hickey BP
    Aust Fam Physician; 1977 Aug; 6(8):983-9. PubMed ID: 303513
    [No Abstract]   [Full Text] [Related]  

  • 22. Impact of antimicrobial therapy on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, and Branhamella catarrhalis in children with respiratory tract infections.
    Varon E; Levy C; De La Rocque F; Boucherat M; Deforche D; Podglajen I; Navel M; Cohen R
    Clin Infect Dis; 2000 Aug; 31(2):477-81. PubMed ID: 10987708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of acute and bacterial lower respiratory tract infections with roxithromycin].
    Chabbou A; Belalgia S; Kamel A; Megdiche L
    Tunis Med; 1992 Oct; 70(10):467-71. PubMed ID: 1295159
    [No Abstract]   [Full Text] [Related]  

  • 24. Activity of gemifloxacin against Streptococcus pneumoniae and Haemophilus influenzae.
    Morrissey I; Tillotson G
    J Antimicrob Chemother; 2004 Feb; 53(2):144-8. PubMed ID: 14729748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resistant microorganisms in head and neck infections.
    Mazzulli T
    J Otolaryngol; 2005 Jun; 34 Suppl 1():S2-6. PubMed ID: 16089233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of cefaclor and tetracycline in the treatment of bacterial bronchitis.
    Hurst DJ
    Clin Ther; 1984; 6(2):163-9. PubMed ID: 6231104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Efficacy of roxithromycin in the treatment of lower respiratory tract infections in patients with chronic respiratory disease].
    Marcos Sánchez F; Celdrán Gil J; Llorente Domingo P; Durán Pérez-Navarro A
    An Med Interna; 1991 Jun; 8(6):312-3. PubMed ID: 1888851
    [No Abstract]   [Full Text] [Related]  

  • 28. [Macrolide antibiotics: Streptococcus pneumoniae and Haemophilus influenzae].
    Soriano F; Fernández-Roblas R
    Enferm Infecc Microbiol Clin; 1996 Oct; 14(8):503-4. PubMed ID: 9011211
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pneumonia caused by Haemophilus influenzae. Study in a series of 58 patients].
    Sánchez F; Mensa J; Martínez JA; Angrill J; Marcos MA; Marco F; Coll-Vinent B; Torres A; Soriano E
    Rev Esp Quimioter; 1999 Dec; 12(4):369-74. PubMed ID: 10855018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical trial of bacampicillin in acute bacterial infections.
    Ogunyemi O
    Clin Ther; 1983; 5(5):472-4. PubMed ID: 6352033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial resistance among Streptococcus pneumoniae and Haemophilus influenzae isolates in the United Arab Emirates: 2004-2006.
    Senok A; Al-Zarouni M; Al-Najjar J; Nublusi A; Panigrahi D
    J Infect Dev Ctries; 2007 Dec; 1(3):296-302. PubMed ID: 19734608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibiotic strategies for developing countries: experience with acute respiratory tract infections in Pakistan.
    Qazi SA
    Clin Infect Dis; 1999 Feb; 28(2):214-8. PubMed ID: 10064229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Roxithromycin, a new macrolide antibiotic, in the treatment of infections in the lower respiratory tract: an overview.
    Gentry LO
    J Antimicrob Chemother; 1987 Nov; 20 Suppl B():145-52. PubMed ID: 3323166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of meropenem 3 g once daily for outpatient treatment of infective exacerbations of bronchiectasis.
    Darley ES; Bowker KE; Lovering AM; Harvey JE; Macgowan AP
    J Antimicrob Chemother; 2000 Feb; 45(2):247-50. PubMed ID: 10660511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ceftazidime in the treatment of lower respiratory tract infection.
    Peirce TH; Vig SJ; Ingram PM
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():21-5. PubMed ID: 6352621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triacetyl-oleandomycin in the treatment of upper and lower respiratory tract infections (report on a multicenter study).
    Van Cauwenberghe P
    Quad Antibiot; 1975 Jun; ():122-40. PubMed ID: 1088733
    [No Abstract]   [Full Text] [Related]  

  • 37. An international clinical trial on the efficacy and safety of roxithromycin in 40,000 patients with acute community-acquired respiratory tract infections.
    Marsac JH
    Diagn Microbiol Infect Dis; 1992; 15(4 Suppl):81S-84S. PubMed ID: 1617929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Revaluation of current antimicrobials. Series 18: Roxithromycin].
    Niki Y; Tamaoki J
    Jpn J Antibiot; 1994 Oct; 47(10):1275-82. PubMed ID: 7807689
    [No Abstract]   [Full Text] [Related]  

  • 39. Roxithromycin vs cefaclor.
    Hughes T; Scott WG; Scott HM
    Pharmacoeconomics; 1993 Nov; 4(5):396-8. PubMed ID: 10146876
    [No Abstract]   [Full Text] [Related]  

  • 40. Cost effectiveness of roxithromycin versus cefaclor in Australia.
    Scott WG; Cooper BC; Scott HM; Tilyard MW; Dovey SM
    Pharmacoeconomics; 1995 Jan; 7(1):93-4. PubMed ID: 10155297
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.